Literature DB >> 26712115

Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.

Srinivas Deekonda1, David Rankin2, Peg Davis2, Josephine Lai2, Todd W Vanderah2, Frank Porecca2, Victor J Hruby3.   

Abstract

Here, we report the design, synthesis and structure activity relationship of novel small molecule opioid ligands based on 5-amino substituted (tetrahydronaphthalen-2-yl)methyl moiety with N-phenyl-N-(piperidin-2-yl)propionamide derivatives. We synthesized various molecules including amino, amide and hydroxy substitution on the 5th position of the (tetrahydronaphthalen-2-yl)methyl moiety. In our further designs we replaced the (tetrahydronaphthalen-2-yl)methyl moiety with benzyl and phenethyl moiety. These N-phenyl-N-(piperidin-2-yl)propionamide analogues showed moderate to good binding affinities (850-4 nM) and were selective towards the μ opioid receptor over the δ opioid receptors. From the structure activity relationship studies, we found that a hydroxyl substitution at the 5th position of (tetrahydronapthalen-2yl)methyl group, ligands 19 and 20, showed excellent binding affinities 4 and 5 nM, respectively, and 1000 fold selectivity towards the μ opioid relative to the delta opioid receptor. The ligand 19 showed potent agonist activities 75±21 nM, and 190±42 nM in the GPI and MVD assays. Surprisingly the fluoro analogue 20 showed good agonist activities in MVD assays 170±42 nM, in contrast to its binding affinity results.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  N-Phenyl-N-(piperidin-2-yl)propionamide; Opioid receptors; Opioids; Pain

Mesh:

Substances:

Year:  2015        PMID: 26712115      PMCID: PMC4873254          DOI: 10.1016/j.bmc.2015.11.030

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  22 in total

Review 1.  Non-peptide opioid receptor ligands - recent advances. Part I - agonists.

Authors:  Agnieszka Kaczor; Dariusz Matosiuk
Journal:  Curr Med Chem       Date:  2002-09       Impact factor: 4.530

2.  Backbone alignment modeling of the structure-activity relationships of opioid ligands.

Authors:  Zhijun Wu; Victor J Hruby
Journal:  J Chem Inf Model       Date:  2011-04-25       Impact factor: 4.956

Review 3.  Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications.

Authors:  Ruben S Vardanyan; Victor J Hruby
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

4.  Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.

Authors:  Shainnel O Eans; Michelle L Ganno; Elisa Mizrachi; Richard A Houghten; Colette T Dooley; Jay P McLaughlin; Adel Nefzi
Journal:  J Med Chem       Date:  2015-06-04       Impact factor: 7.446

5.  Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.

Authors:  Srinivas Deekonda; Lauren Wugalter; Vinod Kulkarni; David Rankin; Tally M Largent-Milnes; Peg Davis; Neemah M Bassirirad; Josephine Lai; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem       Date:  2015-08-04       Impact factor: 3.641

6.  Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.

Authors:  András Váradi; Travis C Palmer; Nathan Haselton; Daniel Afonin; Joan J Subrath; Valerie Le Rouzic; Amanda Hunkele; Gavril W Pasternak; Gina F Marrone; Attila Borics; Susruta Majumdar
Journal:  ACS Chem Neurosci       Date:  2015-07-21       Impact factor: 4.418

7.  In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.

Authors:  T H Kramer; P Davis; V J Hruby; T F Burks; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

Review 8.  Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain.

Authors:  Aswini Kumar Giri; Victor J Hruby
Journal:  Expert Opin Investig Drugs       Date:  2013-12-13       Impact factor: 6.206

9.  Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.

Authors:  Srinivas Deekonda; Lauren Wugalter; David Rankin; Tally M Largent-Milnes; Peg Davis; Yue Wang; Neemah M Bassirirad; Josephine Lai; Vinod Kulkarni; Todd W Vanderah; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2015-07-29       Impact factor: 2.823

10.  Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin.

Authors:  A Misicka; A W Lipkowski; R Horvath; P Davis; T H Kramer; H I Yamamura; V J Hruby
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.